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. Clinical background in 36 NSCLC cases. Table S2 . Association of positive EGR1 and KRT18 expression with clinicopathological features in 36 NSCLC cases. Table S3 . Genes differentially expressed between EGR1-overexpressed H1299 cells and control cells. Table S4 . Genes differentially expressed between EGR1-overexpressed H1299 cells and control cells with biological function of cellular growth and proliferation (IPA analysis). Table S5 . Genes differentially expressed between EGR1-overexpressed H1299 cells and control cells with biofunction of cellular movement (IPA analysis). Table S6 . Genes differentially expressed between EGR1-overexpressed H1299 cells and control cells with biological function of gene expression (IPA analysis). Table S1 . Clinical background in 36 NSCLC cases. Male  57  SCC  II  N 0  +  +++   15  Male  61  SCC  II  N 0  +  ++   16 Female  56  SCC  II-III  N 0  ++  ++   17  Male  53  ASC  I-II  N 1  +  +++   18  Male  58  AC  I-II  N 1  +  -19  Male  50  ASC  II  N 0  +++  +++   20  Male  53  SCC  II-III  N 0  +  +   21  Male  74  SCC  II-III  N 1  ++  -22  Male  48  ASC  II-III  N 0  +++  +++   23  Male  58  SCC  I-II  N 0  ++  +++   24  Male  62  AC  II-III  N 1  +++  +   25  Male  57  SCC  II-III  N 1  +  +   26 Female  69  ASC  I-II  N 0  +++  +++   27  Male  58  SCC  II  N 1  ++  -28  Male  59  SCC  II  N 0  ++  +   29  Male  56  SCC  I-II  N 0  ++  +   30  Male  37  SCC  II  N 0  +  -31  Male  62  SCC  II-III  N 0  +  ++   32  Male  75  SCC  II-III  N 0  --33  Male  63  SCC  II  N 0  +  +   34  Male  56  ASC  II  N 1  +++  +++   35 Female  46  AC  I-II  N 0  ++  +++   36  Male  71  AC  I-II  N 
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